share

N1-[3-(Cyclohexylamino)Propyl]-7,8-Dihydrobleomycinamide CAS NO 52198-88-6


Unit Price:

CAS No.:52198-88-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

N1-[3-(Cyclohexylamino)Propyl]-7,8-Dihydrobleomycinamide is a chemically modified derivative of the bleomycin family of glycopeptide antibiotics, designed for enhanced research and development applications. This compound is of significant interest for its potential role in studying DNA interaction mechanisms and as a key intermediate in the synthesis of novel therapeutic agents. It is primarily utilized by pharmaceutical researchers, academic institutions, and biotechnology companies engaged in oncology research and the development of next-generation antitumor compounds.

Application

  • Pharmaceutical Research & Development: Serves as a critical intermediate in the synthesis of novel bleomycin analogs for anticancer drug discovery programs.
  • Biochemical Studies: Used as a tool compound to investigate the structure-activity relationship (SAR) of bleomycins and their mechanism of DNA cleavage.
  • Oncology Research: Employed in in-vitro studies to evaluate the efficacy and selectivity of modified glycopeptide antibiotics against various cancer cell lines.
  • Academic Research: Utilized in university and institutional labs for fundamental research into metal-chelating antibiotics and their biological targets.
  • Process Chemistry: Acts as a building block for the scale-up and process optimization of complex pharmaceutical active ingredients (APIs).

Basic Information

Product Name N1-[3-(Cyclohexylamino)Propyl]-7,8-Dihydrobleomycinamide
CAS No. 52198-88-6
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms 7,8-Dihydrobleomycinamide, N1-[3-(Cyclohexylamino)propyl]-; Bleomycin derivative; N1-(3-Cyclohexylaminopropyl)-7,8-dihydrobleomycinamide; Modified Bleomycin A2; Research Compound 52198-88-6; BLM derivative; Glycopeptide antibiotic intermediate
EINECS Contact for details

Quality Control

Our N1-[3-(Cyclohexylamino)Propyl]-7,8-Dihydrobleomycinamide is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity suitable for research applications. All materials are accompanied by comprehensive analytical data. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request to support your regulatory and research documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This material is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 95.0%
Water Content ≤ 5.0%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.